TPN-672 Maleate

马来酸TPN-672

Report date: 2025/05/27 11:13:26
NME

Base Information

Drug NameTPN-672 Maleate
Drug Alias NameTPN672马来酸马来酸TPN672TPN-672 MaleateTPN-672
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 2a (5-HT2a) receptor antagonistsSerotonin 1a (5-HT1a) receptor agonistsDopamine D2 receptor agonists +[4] 
TargetsSerotonin 2a (5-HT2a) receptorSerotonin 1a (5-HT1a) receptorDopamine D2 receptor +[4] 
Therapy Area/IndicationsSchizophrenia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesShanghai Institute Of Materia Medica, Chinese Academy Of Sciences
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesShandong Tefaman Pharmaceutical Co LtdSuzhou Vigonvita Life Sciences Co LtdShanghai Institute Of Materia Medica, Chinese Academy Of Sciences
Inactive CompaniesJiangsu Kanion Pharmaceutical Co Ltd
Active IndicationsSchizophrenia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A